Edwin J.P. van Asseldonk

Kidney injury molecule–1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells

Takaharu Ichimura, Edwin J.P. van Asseldonk, Benjamin D. Humphreys et al. · Journal of Clinical Investigation · 2008 · 747 citations · Full text

Rat Kidney Tubules, Immunology, Renal Inflammation +22

Treatment with Anakinra Improves Disposition Index But Not Insulin Sensitivity in Nondiabetic Subjects with the Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study

Edwin J.P. van Asseldonk, Rinke Stienstra, Tim B. Koenen et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 148 citations · Full text

One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitus

Edwin J.P. van Asseldonk, Pleun C.M. van Poppel, Dov B. Ballak et al. · Clinical Immunology · 2015 · 68 citations · Full text

Insulin Resistance, Metabolic Syndrome, Type 1 +11

The Effect of the Interleukin‐1 Cytokine Family Members IL‐1F6 and IL‐1F8 on Adipocyte Differentiation

Edwin J.P. van Asseldonk, Rinke Stienstra, Tim B. Koenen et al. · Obesity · 2010 · 39 citations

Adipocyte Differentiation, Immunology, Immune Regulation +17

TLR-3 is Present in Human Adipocytes, but Its Signalling is Not Required for Obesity-Induced Inflammation in Adipose Tissue In Vivo

Dov B. Ballak, Edwin J.P. van Asseldonk, Janna A. van Diepen et al. · PLoS ONE · 2015 · 32 citations · Full text

Innate Immune System, Immunology, Immune Regulation +23